-
Innovation Ranking
New![]()
Innovation Ranking – Fennec Pharmaceuticals Inc
Fennec Pharmaceuticals Inc (Fennec) formerly Adherex Technologies Inc, develops drugs for cancer treatments. The company lead product candidate, Pedmark, for the prevention of cisplatin-induced hearing loss and ototoxicity in children. The company has licensing agreements with Oregon Health & Science University for development of its drug candidates. The company seeks to establish relationships with contract research organizations, universities and other institutions for development of its drug candidates. Fennec is headquartered in Durham, North Carolina, the US.
-
Company Profile
![]()
Fennec Pharmaceuticals Inc – Company Profile
Fennec Pharmaceuticals Inc (Fennec) formerly Adherex Technologies Inc, develops drugs for cancer treatments. The company lead product candidate, Pedmark, for the prevention of cisplatin-induced hearing loss and ototoxicity in children. The company has licensing agreements with Oregon Health & Science University for development of its drug candidates. The company seeks to establish relationships with contract research organizations, universities and other institutions for development of its drug candidates. Fennec is headquartered in Durham, North Carolina, the US.
Add to Basket -
Product Insights
![]()
Net Present Value Model: Pedmark
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Pedmark Drug Details Sodium thiosulfate (Pedmark)...
-
Product Insights
![]()
Hearing Disorders Global Clinical Trials Review, H2, 2017
GlobalData's clinical trial report, “Hearing Disorders Global Clinical Trials Review, H2, 2017" provides an overview of Hearing Disorders clinical trials scenario. This report provides top line data relating to the clinical trials on Hearing Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.